2018
DOI: 10.1590/0103-1104201811812
|View full text |Cite
|
Sign up to set email alerts
|

Trajetórias assistenciais de mulheres entre diagnóstico e início de tratamento do câncer de colo uterino

Abstract: RESUMO O estudo se propôs a analisar as trajetórias na assistência das mulheres residentes no Município do Rio de Janeiro diagnosticadas com câncer de colo uterino que foram encaminhadas para tratamento em unidade de referência na atenção oncológica. Na primeira etapa do estudo, avaliou-se o prazo entre a confirmação do diagnóstico e o início do tratamento das mulheres matriculadas no ano de 2014, tomando como referência o prazo de até 60 dias fixado pela Lei Federal nº 12.372/2012 para início de tratamento do… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
6
0
26

Year Published

2020
2020
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 50 publications
(33 citation statements)
references
References 13 publications
(7 reference statements)
1
6
0
26
Order By: Relevance
“…These initiatives are in line with Ministry of Health recommendations related to the prevention and control of cervical cancer, which is the third most common type of cancer affecting women in Brazil [31]. Pap smear coverage was lower than expected (79.4% in 2013), with regional and sociodemographic disparities [32], and is one of the quality of care indicators recommended by the Program to Improve Access to and Quality in Basic Care [33]. However, this indicator must be analyzed in greater detail, since the majority of these screenings are conducted on women who seek out health services, which indicates the need for active search and other strategies to capture working women and those who do not visit the basic healthcare unit on a routine basis.…”
Section: Plos Onementioning
confidence: 69%
See 1 more Smart Citation
“…These initiatives are in line with Ministry of Health recommendations related to the prevention and control of cervical cancer, which is the third most common type of cancer affecting women in Brazil [31]. Pap smear coverage was lower than expected (79.4% in 2013), with regional and sociodemographic disparities [32], and is one of the quality of care indicators recommended by the Program to Improve Access to and Quality in Basic Care [33]. However, this indicator must be analyzed in greater detail, since the majority of these screenings are conducted on women who seek out health services, which indicates the need for active search and other strategies to capture working women and those who do not visit the basic healthcare unit on a routine basis.…”
Section: Plos Onementioning
confidence: 69%
“…Technical difficulties related to sample collection still remain, compromising the quality of the material collected and the diagnostic capacity of screening, and the age range of women who undergo this testing is also challenging; most women screened are under age 35, although the risk of cervical cancer increases after this age [33].…”
Section: Plos Onementioning
confidence: 99%
“…Entre as estratégias desenvolvidas nas Unidades básicas de saúde na perspectiva de um melhor atendimento à saúde da mulher, evidencia-se o método de colpocitologia oncótica ou exame de Papanicolau que objetiva detectar preferencialmente as lesões precursoras do câncer do colo do útero ou este o mais precocemente possível. (Carvalho, et al 2018).…”
Section: Resultados Eunclassified
“…Alguns estudos têm sido realizados em nível local ou nacional, para a identificação do tempo transcorrido entre o diagnóstico e o primeiro tratamento, assim como os fatores associados aos possíveis atrasos [15][16][17] . Contudo, tais estudos são elaborados por tipos específicos de câncer, tendo importantes restrições do seu escopo quanto ao período e local de origem dos dados, e utilizam coleta de dados em prontuários, entrevistas, ou dados secundários retrospectivos, demonstrando a complexidade na obtenção dessas informações e a inovação trazida pelo PAINEL--Oncologia.…”
Section: Discussionunclassified